communicable disease pertussis (2)

Upload: petronaila-paul

Post on 09-Apr-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    1/18

    COMMUNICABLECOMMUNICABLE

    DISEASEDISEASE

    (PERTUSSIS)

    GROUP MEMBER:

    MAHADI

    NORSAFRAA

    SAFIAH

    RAHMAWATI

    NORIZAN

    SYAKILA

    AMIRA

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    2/18

    DEFINITION OF

    DISEASEA highly contagious bacterial disease that cause

    uncontrollable coughing.

    Coughing can make it hard to breathe. A deep "whooping" sound is often heard when

    patient try to take a breath.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    3/18

    ETIOLOGY:ETIOLOGY:

    an upper respiratory infection

    caused by the Bordetella Pertussis

    or Bordetella Parapertussis bacteria.

    produces Pertussis toxin play a major

    virulence role, which impactthe severity ofillness and induce protective immune

    response.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    4/18

    PHATOPHYSIOLOGY:PHATOPHYSIOLOGY:

    Bordella Pertussis divided into 3 stages whichare:

    1. Catarrhal Stage:

    This begins within incubation periods withnasal congestionand rhinorrhea.

    Patient is the most contagious atthis time.

    This symptom begins to decrease after 1to 2 weeks as paroxysmal stage begins.

    2. Paroxysmal Stage:

    The onset cough marks the begin.

    The paroxysmal stages lasts from 1to 6 weeks and severe cases may last up to10weeks.

    The coughingspells are followed by ahigh pitched whoopingsound upon inhalation.

    Pertussis attacks may become very severe lead the person cyanotic.

    Usually occur atnight.

    3. Convalescent Stage:

    Inthis final recovery stage the number, severity and durationofparoxysms diminished(the cough becomes less violent).

    The paroxysmal episodes usually disappear 2 to 4 weeks inthis stage.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    5/18

    CLINICAL MANIFESTATION:CLINICAL MANIFESTATION:

    Mild upper respiratory infection.

    Cold, sneezing, runny nose, low-grade fever

    and mild cough.

    Cough becomes more severe (2 weeks).

    Numerous rapid coughs followed by high

    pitched whoop.

    A thick, clear mucous discharged from nose.may re occur for 1 - 2 months and more

    frequentatnight.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    6/18

    LABORATORY STUDIES..LABORATORY STUDIES..

    Swab C&S from nose and throat.

    Serologic testing

    Complete Blood Count

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    7/18

    MEDICAL MANAGEMENT..MEDICAL MANAGEMENT..

    Immunization:

    o Vaccine Pertusis.

    o Child at 2, 3, 5 month.

    o

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    8/18

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    9/18

    Isolation 5 day /3 week.

    Antibiotic:

    o Azithromycinand Clarithromycin.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    10/18

    NURSINGNURSINGMANAGEMENTMANAGEMENT

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    11/18

    DIFFICULTY IN BREATHING R/T THICK MUCUS

    PRODUCTION.

    Assess patient vital sign suchas temperature, pulse

    respirationand oxygen saturation (spo2). This is to

    detect early signand symptom suchas tachypnea

    >20/min, tachycardiaand hypoxia

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    12/18

    Administer antibiotic erythromycintablet

    500mgbd tofightagainstthe bacteria bordellapertussis.

    Monitor patients spo2 2 hourly to detect

    changes ofoxygen saturation which cause pttogaspingdue tohypoxia.

    Administer suctionto clear the airway as mucus

    productionhighly secrete.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    13/18

    INEFFECTIVE BREATHING PATTERN R/T

    TO LOW OXYGEN SUPPLY AS EVIDENCE

    BY SHORTNESS OF BREATH. Assess vital signtemperature, pulse, breathing

    and spo2 to detecthypoxia.

    Assess respiratory pattern by pattern (regular orirregular), rate and depthofthe respiration (deep,shallow).

    Position patient infowlers position lungtopromote lungexpansion.

    Administer oxygen 3 liter vianasal prongor asprescribed by doctor ifspo2 is

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    14/18

    HEALTH EDUCATION.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    15/18

    Isolate the person (separate bedroom) until heor she has received five days ofantibiotics.

    Wear a surgical mask to cover their face.

    Practice good hand washing; whooping

    cough bacteria can be transmitted through

    contact with contaminated inanimate objects

    suchas dishes.

    Drink plenty offluids, includingwater, juices,

    soups, and eatfruits to prevent dehydration.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    16/18

    Eat small, frequent meal to decrease theamountofvomiting.

    Donotgive cough medications unless

    otherwise instructed by your doctor. Use a cool mist vaporizer tohelp loosen

    secretions and soothe the cough.

    Keep the home environmentfree fromirritants that cantrigger coughing, suchas

    smoke, aerosols, and fumes.

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    17/18

    COMPLICATION:

    o Respiratory problems :

    atelectasis

    bronchopneumonia, emphysema

    pneumothorax (rare,90

    % ofdeaths)o Effects on CNS (mostfrequent in young infants):

    cerebral hemorrhage

    encephalopathy,

    convulsions, visual disturbances, paralyse.

    mental retardation

    o Malnutrition

  • 8/8/2019 COMMUNICABLE DISEASE pertussis (2)

    18/18

    THANK YOU